metastatic breast cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
metastatic breast cancer
Jun 26, 2024, 03:18 |
Insight
Paolo Tarantino: The 5 S rules help memorizing a simple framework to manage ILD
Paolo Tarantino shared on LinkedIn: “T-DXd is rapidly expanding in indications, from HER2+, to HER2-low, and…
Jun 25, 2024, 16:01 |
Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X: . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 19, 2024, 12:33 |
Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 15, 2024, 04:53 |
Insight
Felipe Rodrigues: Excited to share our work on the reciprocal interaction between metastatic cancer cells and AT2 cells
Felipe Rodrigues, Postdoctoral Researcher at Rockefeller University, recently shared a post on X: "Beyond excited…
Jun 14, 2024, 21:00 |
Blog
Michail Ignatiadis: Humble to have led this EBCC14 manifesto
Quoting Michail Ignatiadis, Director of Breast Medical Oncology Clinic and Program, Jules Bordet Institute, on…
Jun 10, 2024, 16:25 |
Blog
Vicki Durston: Thrilled to announce the launch of our new Metastatic Breast Cancer Media Guide
Vicki Durston, President of the General Assembly and Board Member at ABC Global Alliance, shared…
Jun 10, 2024, 07:18 |
Blog
Francisco J. Esteva: Emerging technologies are set to revolutionize the detection and application of biomarkers in cancer treatment
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 6, 2024, 00:29 |
Blog
Paolo Tarantino: Expansion cohorts from TBCRC by Nadine Tung
Paolo Tarantino shared a post on X: “One of the most important presentations of ASCO24:…
Jun 5, 2024, 15:22 |
Insight
Piotr Wysocki: T-DXd in metastatic ER+/HER2-low breast cancer patients after endocrine treatment failure
Piotr Wysocki recently posted on LinkedIn: "Results of a Destiny-Breast06 trial have been presented by…
May 31, 2024, 15:41 |
Societies
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X: "More than 25 ASCO24…
1
2
3
4
5
6
All:
53
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube